14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.683 3 days ( 11.72 % )
Last Price $1.13 -3.42 %
High/ Low $1.12 - $1.20 5.36%
Chg 7 Days -2.16 % $1.16 $1.13
Chg 30 Days -18.71 % $1.39 $1.13
Chg 12 mos -72.37 % $4.09 $1.13
Trend - 3 mos 17.68 % Width: 88.37 %
Trend - 12 mos -53.08 % Width: 1,580.82 %
Pred. range - 3 mos $1.19 - $2.24 5.01 % - 97.81 %
Pred. range - 12 mos $0.0375 - $0.631 -96.68 % - -44.20 %
Short MA avg 3 mos Sell Apr 18, 2024 - 3 days
Long MA avg 3 mos Buy Apr 16, 2024 - 5 days
Short/Long MA avg 3 mos Sell Apr 09, 2024 - 10 days
Short MA avg 12 mos Buy Apr 16, 2024 - 5 days
Long MA avg 12 mos Buy Feb 01, 2024 - 56 days
Short/Long MA avg 12 mos Buy Feb 07, 2024 - 52 days
Pivot Short Sell Feb 06, 2024 - 53 days
Bollinger Buy Oct 19, 2023 - 127 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics. Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezo... KPTI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT